Why Abzena?
Trust our focused approach.
As an experienced contract research organization (CRO) with our own biotech company roots, we have an intimate understanding of the crucial decisions that you face to work with a proven, trusted biologics partner that can skillfully support and optimize your molecules R&D.
Abzena’s scientific expertise, and the trust that is placed in us by our customers means that we are ready to work together with you to de-risk and streamline the research and development of your biologic or bioconjugate to move your medicine forward.
We have over 20 years of experience working across many modalities including mAbs, ADCs, AOCs, RDCs and Bispecifics.
If you are looking for a biologics CRO or integrated CDMO partner that you can count on, we are ready to help move your medicine forward to the next inflection point.
We offer a uniquely collaborative, personalized, and transparent partnership differentiated by our mission to keep moving medicine forward and our values. Leverage the insights gained from over 20 years of experience, and multiple decades of scientific knowledge across our team today.
We offer best-in-class biologics and bioconjugates CRO + CDMO services along with a highly detailed and personalized experience. Contact us today to find out more about our expanding ADC and AOC services.
From biologics discovery and design to development, through to commercial manufacturing, Abzena offer integrated contract research, development, and manufacturing services for many of the leading pharma, academia and biotech customers. Our scientific experts at our locations in Cambridge UK, Bristol and San Diego USA have experience working with hundreds of molecules across all stages of the drug development process.
A biologics CRO is a Contract Research Organization (CRO) that provides research and development (R&D) services for biologic-derived medicines. They support biopharmaceutical, academia and biotech companies through providing services for discovery, preclinical development, rapid data analysis, and regulatory support specifically for biologics (and bioconjugates).
The leading biologics CDMO + CRO that accelerates drug development, moving medicine forward for patients in need.